BIO VIEW LTD 

$0.97
0
+$0+0% Tuesday 20:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Apr 17
$0.55
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

30SepExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0.01
0
0.02
0.04
Expected EPS
N/A
Actual EPS
0.0248

Financials

0.99%Profit Margin
Profitable
2018
2019
2020
2021
2022
2023
9.52MRevenue
94,644.32Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIVWF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap18.49B
Illumina provides integrated systems for the analysis of genetic variation and biological function, directly competing in the genetic analysis market.
Thermo Fisher Scientific
TMO
Mkt Cap184.37B
Thermo Fisher Scientific offers similar biotechnology product development services, including genetic analysis tools which compete with Bio View's offerings.
Agilon Health
AGL
Mkt Cap315.85M
Agilent Technologies provides instruments, services, and consumables for laboratories, including genetic analysis which is a direct competition to Bio View.
Bio-Rad Laboratories
BIO
Mkt Cap7.54B
Bio-Rad Laboratories manufactures and supplies products and systems used for gene expression which competes with Bio View's genetic analysis technologies.
Qiagen NV
QGEN
Mkt Cap8.43B
QIAGEN offers sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical industry which overlap with Bio View's market.
Pacific Biosciences of California
PACB
Mkt Cap404.68M
Pacific Biosciences provides sequencing systems that compete in the genetic analysis sector, similar to Bio View's products.
Guardant Health
GH
Mkt Cap10.31B
Guardant Health focuses on liquid biopsies and cancer diagnostics, competing in the broader genetic analysis and diagnostics market that Bio View targets.
Fulgent Genetics
FLGT
Mkt Cap450.66M
Fulgent Genetics offers comprehensive genetic testing, directly competing with Bio View in the genetic diagnostics market.
EXACT Sciences
EXAS
Mkt Cap20.03B
Exact Sciences provides cancer screening and diagnostic tests that use genetic analysis, competing in the same space as Bio View.

About

Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company's products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic fluorescent imaging system that automatically scans, analyses, and sorts a range of FISH samples in real-time; and Allegro Plus, an automatic fluorescent imaging system, which identifies various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. It also offers DUET-3, an imaging and analysis platform that include an automated barcode reader, which enables scanning of various test types in a single scan batch; DeNovo, an automated scanning system for detection, analysis, and characterization of circulating tumor cells from peripheral blood; Solo Workstation, an offline workstation that streamlines and enables review and analysis of test results away from the microscope; and SoloWeb, a Web-based solution that provides analysis, reporting, and consulting on BioView-scanned cases. Bio-View Ltd was founded in 2000 and is headquartered in Rehovot, Israel.
Show more...
CEO
Dr. Alan Schwebel
Employees
35
Country
Israel

Listings

0 Comments

Share your thoughts

FAQ

What is BIO VIEW LTD stock price today?
The current price of BIVWF is $0.97 USD — it has increased by +0% in the past 24 hours. Watch BIO VIEW LTD stock price performance more closely on the chart.
What is BIO VIEW LTD stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange BIO VIEW LTD stocks are traded under the ticker BIVWF.
What were BIO VIEW LTD earnings last quarter?
BIVWF earnings for the last quarter are 0.02 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BIO VIEW LTD revenue for the last year?
BIO VIEW LTD revenue for the last year amounts to 9.52M USD.
What is BIO VIEW LTD net income for the last year?
BIVWF net income for the last year is 94,644.32 USD.
Does BIO VIEW LTD pay dividends?
Yes, BIVWF dividends are paid annual. The last dividend per share was 0.55 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does BIO VIEW LTD have?
As of April 15, 2026, the company has 35 employees.
In which sector is BIO VIEW LTD located?
BIO VIEW LTD operates in the Health & Wellness sector.
When did BIO VIEW LTD complete a stock split?
The last stock split for BIO VIEW LTD was on December 24, 2023 with a ratio of 1:10.
Where is BIO VIEW LTD headquartered?
BIO VIEW LTD is headquartered in Rehovot, Israel.